Jennifer Bouey

Photo of Jennifer Bouey
Senior Policy Researcher; Tang Chair in China Policy Studies
Off Site Office


Ph.D. in epidemiology, George Washington University; M.P.H. in epidemiology, George Washington University; M.D. in clinical medicine, Peking University

Media Resources

This researcher is available for interviews.

To arrange an interview, contact the RAND Office of Media Relations at (310) 451-6913, or email

More Experts


Dr. Jennifer Huang Bouey is a senior policy researcher and the Tang Chair in China Policy Studies at the RAND Corporation. As an epidemiologist who led health studies in the United States, China, and several other countries in the last twenty years, her research portfolio centered on health equity, infectious disease prevention, and global health governance. Dr. Bouey served on multiple study sections at the National Institute of Health, and as scientific reviewer for China Natural Science Foundation, Hong Kong AIDS Council, and Hong Kong Government Research Fund. She also provided technical consultancy to the World Bank, Clinton HIV/AIDS Initiative, the Save the Children Federation, Inc., and China’s National and Provincial Centers for Disease Control. She has testified multiple times in front of various committees of the U.S. Congress on China’s public health-, health care-, and global health- related issues. Her work and opinions have appeared in the New York Times, Financial Times, The Global Times, The Atlantic, BBC World, MSNBC, and Bloomberg TV. Prior to RAND, she served as the Susan Mayor Professor for Health Equity at Georgetown Unviersity Global Health program for many years. Dr. Bouey received her Ph.D. in epidemiology from the George Washington University and her Clinical Medicine (M.D.) degree from the Peking University School of Medicine.

Previous Positions

Susan Mayor Professor in Health Equity, School of Nursing and Health Studies, Georgetown University

Selected Publications

Han J*, Bouey JZ*, Wang L, Mi G, Chen Z, He Y, Viviani T, Zhang F, "PrEP Uptake Preferences Among Men Who Have Sex with Men in China: Results from a National Internet Survey," J International AIDS Soc., 22(2), 2019

Stoto MA, Kang M, Song T, Bouey J, Boyce MR, Katz R, "At the frontier of the global battle against emerging infections: surveillance and management of avian influenza A(H7N9) in Guangdong Province, China," J Glob Health Rep , 3, 2019

Shi LJ, Bouey ZJ, Lin L, "Impact of psychological integration and acculturation on mental health among migrant children in Guangzhou, China," BMJ open, 9(5), 2019

Haw, NJ, Yang J, Li H, Lin D, Wang Z, Bouey ZJ* , "Challenges and value of peer outreach workers in needle and syringe exchange programs: Evidence from an HIV prevention program in Yunnan Province, China.," J Ethn Subst Abuse, 15, 2018

Uretsky E, Bouey J, Katz R, "The Changing Paradigm of Global Health with Chinese Characteristics. Global Health Policy," Health Affairs, 2018

11.Chang RC, Hail-Jares K, Zheng H, He N, Bouey ZJ* , "Mitigating circumstances: a model-based analysis of associations between risk environment and infrequent condom use among Chinese street-based sex workers," PloS One, 13(5), 2018

K. Hail-Jares, S. Choi, L. Duo, Z. Luo, *ZJ Huang, "Occupational and Demographic Factors Associated with Drug Use Among Female Sex Workers at the China-Myanmar Border. ," Journal of Alcohol and Drug Dependency., (161), 2016

Huang ZJ, Zheng C, "Type 2 Diabetes among 6 Asian Ethnic Groups in California: The Nexus of Ethnicity, Gender, and Generational Status," J Health Care Poor Underserved, 26(2), 2015


Chinese; English

Recent Media Appearances

Interviews: BBC; Bloomberg Television; CGTN, China Global Television Network; Global Times; People's Daily Online, China; Voice of America Chinese


  • A nurse holds China's Sinovac COVID-19 vaccine at a hospital in Porto Alegre, Brazil, August 8, 2020, photo by Diego Vara/Reuters

    Who Will Benefit from a Successful Chinese COVID-19 Vaccine?

    China, one of the world's largest producers of vaccines, could be among the first to produce one for COVID-19. If that happens, then would China be able to produce sufficient doses for domestic use? And which other countries would likely benefit?

    Aug 12, 2020 The Hill

  • Polygonal image of COVID-19 virus superimposed on a digital world map, photo by Andrii Pokliatskyi/Getty Images

    Global Challenges to Maintaining a Healthy Workforce During a Pandemic: Views from RAND Experts

    As nations across the globe remain in lockdown to curb the spread of the COVID-19 pandemic, questions about the future of employment and workforce productivity emerge. During a recent webinar, RAND experts discussed how to get people back to work and improve productivity post COVID-19.

    May 15, 2020

  • A woman visits her mother who has tested positive for coronavirus at a Seattle-area nursing home, the epicenter of one of the biggest outbreaks in the United States, in Kirkland, Washington, March 11, 2020, photo by Jason Redmond/Reuters

    U.S. COVID-19 Cases on the Rise: Q&A with RAND Experts

    COVID-19, the disease caused by the new coronavirus, is now in all 50 states. And more and more U.S. cases and deaths are being reported. As orders to close schools and restaurants take effect across America, RAND researchers answer some questions about the crisis.

    Mar 18, 2020

  • Volunteers in protective suits disinfect a railway station as China tries to contain an outbreak of coronavirus, Changsha, Hunan province, February 4, 2020, photo by Stringer/Reuters

    Coronavirus Outbreak Intensifies: Q&A with RAND Experts

    Cases of the coronavirus have now spread to several dozens of countries, infecting thousands and thousands of people across the globe. With concerns about the disease rising, we asked a group of RAND researchers to answer a wide range of questions about the crisis.

    Mar 5, 2020

  • Pedestrians walk in the Chinatown district of downtown Toronto, Ontario, after 3 patients with novel coronavirus were reported in Canada January 28, 2020, photo by Carlos Osorio/Reuters

    Is Coronavirus Another SARS?

    In 2002, the SARS pandemic infected more than 8,000 people and killed 774. How is the coronavirus outbreak similar? And how is it different?

    Jan 28, 2020 The World Post